Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer
Trial Details
- NCT ID
- NCT06026943
- Phase
- NA
- Sponsor
- Alpha Tau Medical LTD.
- Status
- RECRUITING
- Cancer Type
- Pancreatic Cancer
- Interventions
- Locations (sample)
- Verona, Italy|45.43854,10.9938
Key Eligibility Criteria
- Histologically and/or cytologically proven NCCN locally advanced PC
- Patients must have i) received at least one line of chemotherapy (any kind) OR ii) are medically unfit for further chemotherapy, AND iii) the tumor…
- DaRT indication validated by a multidisciplinary team.
- Measurable lesion per RECIST (version 1.1) criteria
For full eligibility, visit ClinicalTrials.gov.